GOC Position Statement - Prophylactic HPV Vaccines
July 18, 2006
News release on the HPV Vaccines
- GOC Position Statement Regarding Prophylactic HPV Vaccines (PDF)
- Déclaration de position de la GOC sur les vaccins prophylactiques VPH (PDF)
Important related links:
- CDC (US) Press Release - CDC Advisory Committee Recommends Human Papillomavirus Virus Vaccination
- FDA (US) Press Release- FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus
- SGO Position Statement on a Cervical Cancer Vaccine (PDF)
- SGO Announcement on a Cervical Cancer Vaccine (PDF)
Expert contacts for media inquiries:
- National GOC spokesperson: Dr. K. Joan Murphy, Chair, GOC Task Force on Cervical Cancer Prevention and Control
- Regional GOC spokespersons:
British Columbia: Dr. Tom Ehlen
Alberta:
Saskatchewan: Dr. Christopher Giede
Manitoba: Dr. Robert Lotocki
Ottawa: Dr. Tien Le
Toronto: Dr. K. Joan Murphy
Quebec: Dr. Diane Provencher
New Brunswick: Dr. Réjean Savoie
Nova Scotia: Dr. James Bentley
Newfoundland: Dr. Lesa Dawson
- To speak with any of the spokespersons, please contact Mrs. Hélène Soublière, GOC National Coordinator at 1-800-561-2416 extension 250.

